 |
Jerusalem, Israel, May 12, 2008
Teva To Present At The Bank Of America Health Care Conference
|
|
Jerusalem, Israel, May 6, 2008
Teva Reports First Quarter 2008 Results
|
|
Jerusalem, Israel, April 30, 2008
Teva Announces Global In-Market First Quarter Sales
Of Copaxone® Increased 35% To $542 Million
|
|
Jerusalem, Israel, April 28, 2008
Teva Announces Approval Of Generic Flolan® For Injection
|
|
Jerusalem, Israel, April 23, 2008
Teva To Report First Quarter 2008 Financial
|
|
Jerusalem, April 17, 2008
Teva Announces Tentative Approval Of Generic Evista® Tablets
|
|
Jerusalem, April 17, 2008
Teva Announces Tentative Approval Of Generic Maxalt® Tablets
|
|
Jerusalem, April 16, 2008
Early Treatment With Copaxone® Significantly Delayed
Progression To Clinically Definite Multiple Sclerosis
|
|
Jerusalem, Israel, April 11, 2008
Teva Announces Brussels Court Decision To Revoke MSD's European Patent On Fosamax®
|
|
Jerusalem, Israel, April 11, 2008
Teva Receives Court Ruling Awarding Exclusivity For Generic Risperdal®
|
|
Jerusalem, Israel, April 10, 2008
Copaxone® Significantly Reduced Annual Relapse Rates And Stabilized Disease Progression In Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
|
|
Jerusalem, Israel, March 31, 2008
Teva Provides Update On Generic Prevacid® Litigation
|
|
Jerusalem, Israel and Exeter, NH, March 31, 2008
Teva to Acquire Bentley Pharmaceuticals
|
|
Jerusalem, Israel, March 28, 2008
Teva Provides Update On Generic Aricept® Litigation
|
|
Jerusalem, Israel, March 25, 2008
Teva Reports 2007 Financials in XBRL Standard
|
|
Jerusalem, Israel, March 17, 2008
Teva to Present at the Lehman Brothers 11th Annual Global Healthcare Conference and at the Cowen and Company 28th Annual Healthcare Conference
|
|
Jerusalem, Israel, March 13, 2008
Teva Provides Update On Glatiramer Acetate 40mg For Amyotrophic Lateral Sclerosis (ALS)
|
|
Jerusalem, Israel, March 12, 2008
Teva To Present At The Bear Stearns 10th Annual London Healthcare Conference
|
|
Jerusalem, Israel, March 5, 2008
Teva Provides Update On Generic Risperdal®
|
|
Jerusalem, Israel, February 29, 2008
Teva Provides Update On Generic Actonel® Litigation
|
|
Jerusalem, Israel, February 28, 2008
Teva Announces Approval Of Generic Camptosar®
|
|
Jerusalem, Israel, February 25, 2008
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax®
|
|
Jerusalem, Israel, February 21, 2008
Teva's Developed G-CSF is the First Biosimilar to Receive a Positive Opinion from European Union Regulators
|
|
Jerusalem, Israel, February 21, 2008
Teva Presents Growth Strategy At Investor Day
Company Provides Long Term Strategic Goals
Teva Announces Closing Of Cogenesys Acquisition
|
|
Jerusalem, Israel, February 19, 2008
Teva Invites Public To Listen To Investor Day Webcast
|
|
Jerusalem, Israel, February 12, 2008
Teva Provides 2008 And 2009 Financial Outlook
|
|
Jerusalem, Israel, February 12, 2008
Teva Reports Fourth Quarter And Full Year 2007 Results
|
|
Jerusalem, Israel, February 6, 2008
Teva Announces Approval of Generic Fosamax® Tablets
|
|
Jerusalem, Israel, February 1, 2008
Teva Provides Update On Generic Protonix®
|
|
Jerusalem, Israel, January 31, 2008
Teva Announces Tentative Approval Of Generic Flomax® Capsules
|
|
Jerusalem, Israel, January 30, 2008
Teva Announces Wyeth Voids Standstill Agreement On Generic Protonix®
|
|
Jerusalem, Israel, January 29, 2008
Teva To Present At The 2008 Wachovia Healthcare Conference
|
|
Jerusalem, Israel, January 29, 2008
Teva To Report Fourth Quarter And Full Year 2007 Financial Results On February 12, 2008
|
|
Jerusalem, Israel, January 23, 2008
Teva Announces Tentative Approval Of Generic Prevacid® Delayed-Release Capsules
|
|
Jerusalem, Israel, January 22, 2008
Teva Announces Extension To Standstill Agreement On Generic Protonix®
|
|
Jerusalem, Israel, January 22, 2008
Teva to Acquire CoGenesys
Acquisition Will Bolster Teva's Biotechnology Capabilities
|
|
Jerusalem, Israel, January 17, 2008
Teva Announces Approval Of Pravastatin Sodium Tablets, 80 Mg
|
|
North Wales, Pa. and Atlanta, January 16, 2008
Teva Specialty Pharmaceuticals And UCB Announce U.S. Respiratory Collaboration Agreement
|
|
Jerusalem, Israel, January 14, 2008
Teva Announces Tentative Approval Of Generic Aricept® Tablets
|
|
Jerusalem, Israel, January 14, 2008
Teva to Explore Strategic Alternatives for its Animal Health Business
|
|
Jerusalem, Israel, January 10, 2008
Teva Announces Departure Of North American CEO ,
William S. Marth To Become Ceo Of Teva North America
|
|
Jerusalem, Israel, January 3, 2008
Teva To Present At The Morgan Stanley Pharmaceutical CEO's Unplugged Conference And At The 26th Annual Jpmorgan Healthcare Conference
|
|
Jerusalem, Israel, January 3, 2008
Teva Announces Approval Of Generic Kytril® Injection And Tablets
|
|
Jerusalem, Israel, January 2, 2008
Teva Announces Approval Of Generic Duoneb®
|
